Clinical Trial Update: Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing T4030 Eye Drops with Ganfort in patients with ocular hypertension or glaucoma has completed, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Ganfort (bimatoprost; timolol)
• T4030 Eye Drops

Snippet

Sponsor: Laboratoires Thea | Conditions: Ocular Hypertension Glaucoma | Phase 3 | Status: COMPLETED